SCHEMBL15768706

SCHEMBL15768706

O=C(Nc1ccnnc1)C1CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.53
ROCK1 Q13464 4/20 0.53
NAMPT P43490 1/20 0.51
ABL1 P00519 1/20 0.51
PKN2 Q16513 3/20 0.50
TP53 P04637 3/20 0.50
RPS6KA5 O75582 2/20 0.50
LRRK2 Q5S007 2/20 0.50
LMNA P02545 2/20 0.50
CYP3A4 P08684 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CHUK O15111 1/20 0.50
PRKD3 O94806 1/20 0.50
CDK1 P06493 1/20 0.50
CDK2 P24941 1/20 0.50
LTK P29376 1/20 0.50
CDK8 P49336 1/20 0.50
PRKX P51817 1/20 0.50
CDK5 Q00535 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1554477 0.88 ROCK2 (0.45) ROCK2ROCK1NAMPTABL1PKN2
SCHEMBL1554480 0.88 ROCK2 (0.45) ROCK2ROCK1NAMPTABL1PKN2
SCHEMBL19132806 0.86 RORC (0.48) ROCK2ROCK1NAMPTABL1PKN2
SCHEMBL15531012 0.85 KHK (0.40) ROCK2ROCK1ABL1PKN2TP53
SCHEMBL7520976 0.79 ROCK2 (0.76) ROCK2ROCK1NAMPTPKN2TP53
SCHEMBL30828553 0.79 ROCK2 (0.76) ROCK2ROCK1NAMPTPKN2TP53
SCHEMBL19132825 0.79 ROCK2 (0.47) ROCK2ROCK1NAMPTABL1PKN2
SCHEMBL19132813 0.79 RORC (0.46) ROCK2ROCK1NAMPTABL1PKN2
Hydrochloric Acid SCHEMBL27545321 0.78 ROCK2 (0.73) ROCK2ROCK1NAMPTPKN2TP53
SCHEMBL18038519 0.77 GSK3A (0.67) NAMPTLMNAMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9765054-B2 Histone deacetylase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. (US) 2017-09-19 US disclosed
US-20140163009-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163009-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF HDAC1, HDAC7, HDAC5 ROCK2 2264/4885ROCK1 2051/4885NAMPT 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.